Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05156268
Title A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Memorial Sloan Kettering Cancer Center Basking Ridge New Jersey 07920 United States Details
Maria Rubinstein Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Bergen Montvale New Jersey 07645 United States Details
Maria Rubinstein Commack New York 11725 United States Details
Maria Rubinstein Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Maria Rubinstein Rockville Centre New York 11553 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field